Hero Cover

BPC-157

A synthetic peptide that accelerates healing of soft tissue, tendons, and the digestive tract.

Quickstart Highlights

BPC-157 (pentadecapeptide) is widely studied preclinically for cytoprotection, angiogenesis, and tissue repair mechanisms. Human dosing standards are not established; the schedules below reflect commonly referenced research practices, not medical advice.

  • Reconstitute: Add 3.0 mL bacteriostatic water (max recommended) → ~1.67 mg/mL concentration.

  • Typical daily range: 200–300 mcg once daily (Standard) or 250 mcg twice daily (Advanced)

  • Easy measuring: At ~1.67 mg/mL, 1 unit = 0.01 mL ≈ 16.7 mcg on a U‑100 insulin syringe. 200–300 mcg → 12–18 units

  • Cycle length: 4–8 weeks depending on results

  • Storage: Lyophilized: store at room temperature in a dark spot or kept in its box; after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F). Avoid repeated freeze–thaw cycles.

Dosing & Reconstitution Guide

1. Standard / Gradual Approach (3 mL = ~1.67 mg/mL)

Phase

Dosage (mcg)

Units (per injection) (mL)

Weeks 1–2

200 mcg (1× daily)

12 units (0.12 mL)

Weeks 3–6

250 mcg (1× daily)

15 units (0.15 mL)

Weeks 7–8 (Optional)

300 mcg (1× daily)

18 units (0.18 mL)

Why 3 mL? Using the largest reconstitution volume helps keep per-injection measurements at or above ~10 units for accuracy on 100-unit syringes. If a very low individual dose ever falls under ~10 units, consider using 50‑unit or 30‑unit insulin syringes for finer gradations.

Reconstitution Steps

  • Draw 3.0 mL of bacteriostatic water with a sterile syringe.

  • Inject the water slowly into the vial, aiming against the vial wall to avoid foaming.

  • Gently swirl or roll the vial until the powder fully dissolves (do not shake vigorously).

  • Refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.

2. Advanced / Aggressive Approach (2 mL = 2.5 mg/mL)

Phase

Dosage (mcg)

Units (per injection) (mL)

Weeks 1–4

250 mcg (2× daily)

10 units (0.10 mL)

Weeks 5–8 (Optional)

250 mcg (2× daily)

10 units (0.10 mL)

Using 2.0 mL yields 25 mcg per unit, keeping twice-daily injections at practical volumes while staying above ~10 units per injection.

Reconstitution Steps

  • Draw 2.0 mL of bacteriostatic water with a sterile syringe.

  • Inject the water slowly into the vial, aiming against the vial wall to avoid foaming.

  • Gently swirl or roll the vial until the powder fully dissolves (do not shake vigorously).

  • Refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.

Supplies Needed

Approximate quantities for common 4–8 week designs.

  • Peptide Vials (BPC-157 5mg):
    • 6 wks Standard ≈ 2 vials (≈9.8 mg total)
    • 8 wks Standard ≈ 3 vials (≈14 mg)
    • 8 wks Advanced (2×/day) ≈ 6 vials (≈28 mg)


  • Insulin Syringes:
    • 6 wks 1×/day ≈ 42
    • 8 wks 1×/day ≈ 56
    • 8 wks 2×/day ≈ 112


  • Bacteriostatic Water (10 mL bottles): 2–3× 10 mL bottles (reconstitute each vial with 2–3 mL)


  • Alcohol Swabs: One for vial stopper + one for skin per injection.

    • Per week: 14 swabs (2/day)

    • 8 weeks: 112 swabs → recommend 2 × 100‑count boxes

Protocol Overview

Concise summary of the once‑daily regimen.

  • Goal: Promotes muscle and tendon repair, support gut and stomach lining health, reduces inflammation and pain.

  • Schedule: Daily subcutaneous injections for 4–8 weeks

  • Dose Range: 200–300 mcg once daily (3 mL dilution keeps ≥10 units). For advanced dosing, 250 mcg twice daily (2 mL dilution → 10 units per injection).

  • Cycle: 4–8 weeks depending on study aim and observations

  • Reconstitution: 3.0 mL per 5 mg vial for flexible, accurate dosing. (or 2 mL for the advanced approach).

  • Storage: Lyophilized vials frozen; reconstituted solution refrigerated; avoid refreezing.

‼️ Important Notes

Practical considerations for consistency and safety.

  • Use a new sterile insulin syringe for each injection and dispose of needles in a proper sharps container.

  • Rotate injection sites (abdomen, thigh, upper arm) to minimize local irritation or tissue changes over time.

  • Inject slowly and steadily; after injection, wait a few seconds before withdrawing the needle to prevent leakage.

  • Maintain a log of daily dose and injection site to ensure consistent rotation and monitor your regimen.

General subcutaneous injection guidance (for educational purposes).

  • Clean the vial’s rubber stopper and your chosen injection site with alcohol swabs; let them air-dry.

  • Using an insulin syringe, pinch a fold of skin and insert the needle at a 45–90° angle into the subcutaneous tissue (fat layer).

  • Do not aspirate (no need to pull back on the plunger) for subcutaneous injections. Inject the peptide slowly and steadily.

  • After injection, dispose of the syringe safely. Rotate injection sites (abdomen, thighs, upper arms) to prevent irritation or scar tissue build-up.

Potential Benefits & Side Effects

Key mechanisms reported in preclinical literature:

  • Angiogenesis: Engagement of VEGFR2–Akt–eNOS signaling; pro-angiogenic effects in ischemia and tube-formation assays

  • NO System Modulation: Endothelium-dependent vasodilation influenced by nitric-oxide pathways

  • Cytoprotection: Protection of GI mucosa and multi-organ tissues consistent with “cytoprotection” frameworks

  • Tendon/Soft-Tissue Models: Accelerated healing and cell migration in tendon and myotendinous junction studies

Potential side effects:

  • Injection-site irritation or erythema

  • Regulatory and anti-doping compliance requirements


Important Note

This content is intended for educational purposes only and is not medical advice, diagnosis, or treatment.

Legal Disclaimer

All products listed, sold, mentioned, acquired on or through this website are intended strictly for laboratory and research purposes only. They are not for human consumption, veterinary use, or any form of in vivo experimentation. These materials are provided solely for qualified individuals, institutions, and professionals engaged in legitimate scientific research and testing.

By accessing this website, making an inquiry, or placing an order, you acknowledge and agree that:

  1. You are a qualified researcher, scientist, or institutional representative with the appropriate knowledge and facilities to safely handle materials of this nature.

  2. You understand and accept that the products are not to be used for any other purposes, including but not limited to medical, diagnostic, therapeutic, or recreational use.

  3. You understand that the products supplied are not approved by the FDA, EMA, or any other regulatory authority for human or animal use.

  4. You will use all products solely in accordance with applicable laws, regulations, and safety standards, and will not resell, distribute, or otherwise make them available for any prohibited purpose.

  5. You assume full responsibility for compliance with all applicable laws, regulations, and safety procedures regarding the handling, storage, and use of research chemicals and peptides.

  6. By contacting, communicating with, or purchasing from this website, you confirm your compliance with these conditions and agree to be bound by all associated terms and conditions.

The site owner, operators and its affiliates shall not be held liable for any misuse, handling errors, or consequences arising from improper application of these materials.